IMP Kit Reconciliation and Drug Accountability in Clinical Trials
In a clinical trial, every unit of investigational medicinal product has to be accounted for from the moment it arrives at a site to the moment it is returned or destroyed. That is drug accountability, and IMP kit reconciliation is how you prove it: a continuous, auditable record that what was received, dispensed, returned and destroyed all add up. A gap in that record is a monitoring finding, and in the worst case a question over the integrity of the data. This guide explains the lifecycle, the records that matter, and where reconciliation breaks down.
Why drug accountability matters
Drug accountability protects two things: patient safety and data integrity. It confirms that patients received the right investigational product, that unused and returned product is controlled, and that nothing is unaccounted for. Regulators and sponsors expect it under GCP, and a monitor will reconcile the site's records against the shipment and dispensing records at every visit.
The IMP kit lifecycle
- 1
Receipt and quarantine
Kits arrive at the site, are checked against the shipment, and are held in quarantine until released for use, with temperature on arrival confirmed.
- 2
Storage
Released kits are stored under the required conditions, monitored, with access controlled and stock visible.
- 3
Dispensing
Kits are dispensed to subjects per the protocol and randomisation, with each dispensing recorded against the subject and visit.
- 4
Return
Used and unused kits are returned by subjects and logged, so compliance and accountability can be assessed.
- 5
Reconciliation and destruction
Received, dispensed, returned and remaining quantities are reconciled, and product is destroyed on authorisation, with the destruction recorded.
What reconciliation has to add up
At any point, the numbers have to reconcile: received equals dispensed plus returned plus on-hand plus destroyed. If they do not, the discrepancy has to be explained. A clean reconciliation is a simple equation backed by records that agree, at the site, in the shipment history and in the CTMS.
| Quantity | Source |
|---|---|
| Received | Shipment and site receipt records. |
| Dispensed | Dispensing log against subject and visit. |
| Returned | Subject return log. |
| On hand | Current site inventory. |
| Destroyed | Authorised destruction record. |
Where reconciliation breaks down
- Records in different systems. The shipment portal, the site spreadsheet and the CTMS disagree, and nobody can say which is right.
- Missing temperature on receipt. A kit is received but its condition on arrival was never confirmed.
- Untracked returns. Returned kits are not logged promptly, so the numbers drift.
- Destruction without a record. Product is destroyed but the authorisation or the record is missing.
Frequently asked questions
IMP kit reconciliation is the process of accounting for every unit of investigational medicinal product across a clinical trial: confirming that the quantity received equals the quantity dispensed, returned, on hand and destroyed, with records at the site, in the shipment history and in the CTMS that agree. It is how drug accountability is demonstrated.